In Vitro Susceptibility to Miltefosine of Leishmania infantum (syn. L. chagasi) Isolates from Different Geographical Areas in Brazil

Treatment of visceral leishmaniasis in Brazil still relies on meglumine antimoniate, with less than ideal efficacy and safety, making new therapeutic tools an urgent need. The oral drug miltefosine was assayed in a phase II clinical trial in Brazil with cure rates lower than previously demonstrated...

Descripción completa

Detalles Bibliográficos
Autores principales: Espada, Caroline Ricce, Levatti, Erica V. de Castro, Boité, Mariana Côrtes, Lamounier, Dorcas, Alvar, Jorge, Cupolillo, Elisa, Costa, Carlos Henrique Nery, Rode, Joelle, Uliana, Silvia R. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228039/
https://www.ncbi.nlm.nih.gov/pubmed/34198947
http://dx.doi.org/10.3390/microorganisms9061228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228039/
https://www.ncbi.nlm.nih.gov/pubmed/34198947
http://dx.doi.org/10.3390/microorganisms9061228

Ejemplares similares